Dec 20, 2024 | Defective Drugs, Defective Product, Product Liability, Tepezza Injuries
Tepezza (teprotumumab) has gained attention as a groundbreaking treatment for Thyroid Eye Disease (TED), a rare autoimmune condition that causes inflammation and tissue expansion around the eyes. Approved by the U.S. Food and Drug Administration (FDA) in 2020, Tepezza...
Nov 27, 2024 | Defective Drugs, Defective Medical Device, Personal Injury, Product Liability, Tepezza Injuries
Tepezza, a medication approved by the FDA in 2020 for the treatment of thyroid eye disease (TED), has been a game-changer for individuals suffering from this rare and debilitating condition. However, alongside its success in managing symptoms of TED, growing concerns...
Oct 28, 2024 | Defective Drugs, Defective Product, Product Liability, Tepezza Injuries
Tepezza, a medication originally intended to treat thyroid eye disease (TED), has recently been linked to serious hearing complications, including permanent hearing loss, tinnitus, and other auditory issues. Although Tepezza was granted fast-track approval by the FDA...
Aug 28, 2024 | Defective Drugs, Defective Medical Device, Defective Product, Medical News, Ozempic Injury, Ozempic Lawsuit, Ozempic Lawsuits, Product Liability
The rise in popularity of medications like Ozempic, primarily used to manage type 2 diabetes, has brought both benefits and risks to the forefront of public attention. While it has proven effective in controlling blood sugar levels and aiding in weight loss, recent...
Aug 14, 2024 | Defective Drugs, Defective Product, Medical News, Ozempic Injury, Ozempic Lawsuit, Ozempic Lawsuits, Product Liability
Ozempic, a medication primarily used to manage type 2 diabetes, has garnered significant attention due to its ability to help control blood sugar levels and promote weight loss. However, like many pharmaceuticals, Ozempic comes with potential side effects. Among...
